Register entry
Novartis Innovative Technologies Inc.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 38
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Novartis Innovative Technologies Inc. | 2512 S. TriCenter Blvd., Durham, North Carolina (NC) 27713, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3015404862117213478 |
Catalogue
Drug listings by form and route
3838 active NDC listings: 38 human prescription drug. By marketing category: BLA 38.
| Dosage form | NDCs |
|---|---|
| kit | 37 |
| injection, suspension | 1 |
| Route | NDCs |
|---|---|
| intrathecal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| novartis innovative technologies inc. | 38 |
Catalogue
Marketed products
38| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ITVISMA | onasemnogene abeparvovec-brve | injection, suspension, intrathecal | 71894-200BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-120BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-121BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-122BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-123BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-124BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-125BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-126BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-127BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-128BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-129BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-130BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-131BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-132BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-133BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-134BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-135BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-136BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-137BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-138BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-139BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-140BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-141BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-142BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-143BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-144BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-145BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-146BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-147BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-148BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-149BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-150BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-151BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-152BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-153BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-154BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-155BLA |
| Zolgensma | onasemnogene abeparvovec-xioi | kit | 71894-156BLA |
Neighbours
Registered in the same town
12- Almac Clinical Services, LLCDurham, NC · 3 sites
- Merck & Co., Inc.Durham, NC · 2 sites
- KBI Biopharma, Inc.Durham, NC · 2 sites
- PETNET Solutions, Inc.DURHAM, NC
- Novo Nordisk Inc.Durham, NC
- Eli Lilly and CompanyDurham, NC
- Encube Ethicals LimitedDurham, NC
- Oxford Biomedica (UK) LimitedDurham, NC
- United Therapeutics CorporationDurham, NC
- Aurolife Pharma LLCDurham, NC
- Avista Pharma Solutions, Inc. dba CambrexDurham, NC
- BioAgilytix Labs, LLCDurham, NC
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Novartis Innovative Technologies Inc. FDA approved?
- Novartis Innovative Technologies Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Novartis Innovative Technologies Inc.'s drugs manufactured?
- The FDA register lists Durham, NC. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Novartis Innovative Technologies Inc. make?
- 38 products are listed under Novartis Innovative Technologies Inc. in the openFDA NDC Directory, most often as kit; injection, suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.